Skip to main content

Thalamocortical-auditory network alterations following cuprizone‐induced demyelination



Demyelination and remyelination are common pathological processes in many neurological disorders, including multiple sclerosis (MS). Clinical evidence suggests extensive involvement of the thalamocortical (TC) system in patients suffering from MS.


Using murine brain slices of the primary auditory cortex, we investigated the functional consequences of cuprizone-induced de- and remyelination on neuronal activity and auditory TC synaptic transmission in vitro.


Our results revealed an impact of myelin loss and restoration on intrinsic cellular firing patterns, synaptic transmission, and neuronal plasticity in layer 3 and 4 neurons of the auditory TC network. While there was a complex hyper- and depolarizing shift of the resting membrane potential, spontaneous and induced action potential firing was reduced during demyelination and early remyelination. In addition, excitatory postsynaptic potential amplitudes were decreased and induction of LTP was reduced during demyelination.


These data indicate that demyelination-induced impairment of neurons and network activity within the TC system may underlie clinical symptoms observed in demyelinating diseases, corroborating human findings that disease progression is significantly correlated with microstructural tissue damage of the TC system. Further investigation into focal inflammation-induced demyelination models ex vivo and in vivo are needed to understand the functional implication of local and remote lesion formation on TC network activity in MS.


Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease in which myelin sheaths wrapping the axons in the brain and spinal cord are damaged [1]. The symptoms of the majority of patients with MS usually begin with alternating periods of neurological disability and recovery that can last for many years. Slowly expanding demyelination accompanied by axonal damage and neuronal degeneration is well-accepted pathological hallmarks of neurological deficits in MS, and mechanisms resulting in remyelination of axons are thought to be important for restoration of neuronal function following relapses [2].

Myelin loss affects the integrity of neuronal networks and their synaptic plasticity [3]. Abnormalities in the spontaneous firing patterns of neurons have been reported in both in vitro and in vivo models of peripheral demyelinated axons [46]. In the central nervous system (CNS), myelin loss was demonstrated to cause highly heterogeneous alterations in nodes of Ranvier, thereby affecting the excitability of neocortical pyramidal neurons [7]. Scarce data exist on the effect of remyelination on the neuronal network activities. In addition to neuronal damage, demyelination induced abnormal patterns of cortical synaptic plasticity in a group of MS patients [8] and in different animal models of demyelination [9]. Enhancement of synaptic plasticity in the motor cortex due to the alteration of the functional properties of surviving neuronal circuits has been suggested as a crucial factor for recovery from relapse-associated neuronal damage in MS patients [10].

The auditory thalamocortical pathway is the only neural substrate that sends precise frequency information to the auditory cortex [11]. Impaired thalamocortical auditory connectivity underlies the functional abnormalities in several neurological disorders, such as epilepsy, autism, and schizophrenia [1214]. Increasing evidence suggests extensive involvement of the thalamocortical pathway in patients with MS [15]. Any disruption in this topographically organized circuit and distortions in the temporal processing of frequency information may trigger the symptoms observed in MS [16, 17]. Indeed, the myelin sheath breakdown along the auditory pathway was accompanied by abnormalities of axonal conduction and auditory deficits in MS patients [18]. Abnormalities in auditory evoked potentials and the cognitive P300 wave indicated dysfunction of different regions of the central auditory pathway and pointed to a predictive value of different evoked potentials [19, 20]. Several toxins have been used to produce demyelination in animals, including cuprizone. Feeding of cuprizone, a copper-chelating mitochondrial toxin, induces oligodendrocyte injury and demyelination in different brain regions, preferentially in the corpus callosum. Cuprizone-induced demyelination is usually followed by complete remyelination within a few weeks. Thus, cuprizone treatment serves a useful animal model for investigation of the processes involved in demyelination and consequent remyelination [2123]. To study how demyelination may affect neuronal function and synaptic transmission of the thalamocortical system, we used the cuprizone-mediated demyelination/remyelination model to investigate single cortical neuron properties as well as synaptic plasticity under demyelinated and remyelinated conditions in the auditory cortex in vitro.



Thirty-seven C57BL6 mice (8–12 weeks old) were group-housed (four animals per cage) under a constant temperature (20–22 °C) and 12-h lighting cycle, and during this time, food pellets and water were available ad libitum. All experiments were conducted according to the guiding principles for the care and use of animals in the University of Münster, Germany (LANUV approval AZ 87-51.04.2010.A331).

Experimental design

Mice were divided randomly into four groups: (i) control group which received normal powdered chow for 5–6 weeks (n = 6), (ii) cuprizone group that was fed powdered chow mixed with 0.2 % cuprizone for 5–6 weeks (n = 9), (iii) 7 days remyelination group that received normal diet for 7 days after 5–6 weeks of cuprizone diet (n = 11), and (iv) 25 days remyelination group which received normal diet for 25 days after 5–6 weeks of cuprizone diet (n = 11). All mice from different groups were sex- and age-matched [24].

Slice preparation

The experiments were carried out on brain slices (500 μm) containing the primary auditory cortex (A1), the thalamic medial geniculate nucleus, the lateral geniculate nucleus, the nucleus reticularis thalami, the ventrobasal nuclear complex, and functional thalamocortical projections. Slices were prepared as previously described [25]. Briefly, the brain was removed under deep isoflurane anesthesia (Abbott, Wiesbaden, Germany). Brains were glued with the dorsal side onto a 25° agar-ramp and then were placed into a vibratome and superfused with 4 °C artificial cerebrospinal fluid (ACSF). The ACSF contained (in mmol/l): NaCl 124, KCl 4, CaCl2 1.0, NaH2PO4 1.24, MgSo4 1.3, NaHCO3 26, and glucose 10. The ACSF was continuously equilibrated with 5 % CO2 in O2, stabilizing the pH at 7.35–7.4. Slices were pre-incubated at 28 °C for 60 min in ACSF. After 30 min pre-incubation, CaCl2 was elevated to 2.0 mmol/l. Thereafter, slices were transferred to an interface recording chamber and superperfused with ACSF at 32 °C.

Electrophysiological recordings

Intracellular recordings were performed in the layer 4 of the primary auditory cortex (A1); using sharp microelectrodes filled with 2 mol/l potassium methylsulphate (connected to a 2 mol/l KCl solution-bridge through a ceramic junction; 60–100 MΩ, 32 °C). We used sharp electrodes instead of whole-cell patch-clamp electrodes to diminish the alteration of the intracellular compartment as far as possible. After impaling, neurons revealed frequent periods of spontaneous action potential (AP) firing. A stable resting membrane potential (RMP) ranging from −48 to −63 mV was determined during periods when neurons were not spontaneously active. A constant positive or negative current was injected into individual neurons to set the membrane potential to −40 or −70 mV. The reference electrode and the connection to the microelectrodes were symmetric silver-silver chloride bridges. Intracellular current pulses were passed via an active bridge circuit, and bridge balance was monitored and adjusted during intracellular recordings. The following criteria were considered for the inclusion of data in the study: (i) recording stability without any sign of injury discharges and (ii) RMP more negative than −45 mV with deviation less than 5 % during the control recording period [26]. A bipolar extracellular stimulating electrode was placed in the thalamocortical projections in rostral position with respect to the cortex and inhibitory and excitatory postsynaptic potentials (IPSPs and EPSPs) were evoked in the primary auditory cortex (see inset in Fig. 4). The traces were digitized by a Digidata 1200 (Axon Instruments, CA, USA), and the data were collected and analyzed by Axoscope 10 (Axon Instruments, CA, USA).

The amplitude of APs was measured from RMP baseline to peak. The duration of action potentials was measured as the half-amplitude width. The amplitude of afterhyperpolarizations (AHP) of APs was measured from RMP to the peak of deflection [27].


Electrical stimulations were applied via a bipolar platinum electrode attached to the thalamocortical projections in rostral position in respect to the cortex (see inset in Fig. 5). Using extracellular glass microelectrodes (150 mmol/l NaCl; 2–10 MΩ), extracellular local field potentials were recorded in the third layer of the auditory neocortical slices. Stimulation intensity was decreased to bring the evoked field excitatory postsynaptic potential (fEPSP) amplitude to approximately 50 % of maximum amplitude. In long-term potentiation (LTP) experiments, the auditory cortex was repeatedly stimulated once every minute. The tetanic stimulation consisted of a 100-ms long train of 100-Hz electrical pulses. The duration of the electrical pulse was 0.1 ms with an interpulse interval of 10 ms. Four trains were delivered to the thalamocortical projections with a train interval of 100 ms. LTP was described as the mean alteration in fEPSP amplitude (measured from the most positive to the most negative deflection) in response to five stimuli given 30 min after tetanic stimulation compared to the mean response to five pulses applied immediately before tetanic stimulation. fEPSP recordings were monitored and analyzed using WinLTP [28].

Immunohistopathological studies

Immunohistochemistry was performed for each time point, namely week 0 for control, week 6 for demyelination, and then at 7 and 25 days of remyelination. Briefly, mice were perfused with 4 % paraformaldehyde (PFA) in phosphate buffer via the left cardiac ventricle as previously described [29]. Brains were removed, postfixed in 4 % PFA, and paraffin-embedded. For light microscopy, 7-μm serial paraffin sections were cut and dried at 37 °C overnight, as described before [23]. Paraffin-embedded sections were de-waxed, rehydrated, and microwaved for 5 min in 10 mM citrate buffer (pH 6.0). Sections were quenched with H2O2, blocked for 1 h in phosphate-buffered solution containing 3 % normal goat serum, 0.1 % Triton X-100, and then incubated overnight with the primary antibody. The primary antibody for myelin proteolipid protein (PLP; mouse IgG2a, 1:500, Serotec) was used to detect de- and remyelination. After washing, sections were further incubated with biotinylated anti-mouse IgG (heavy and light chain) secondary antibodies (1:500, Vector Laboratories) for 1 h followed by peroxidase-coupled avidin-biotin complex (ABC Kit, Vector Laboratories). Reactivity was visualized with diamino-3,3′-benzidine (Vector Laboratories). For cell staining, slides were counterstained using Mayer’s hemalum solution (Merck). The extent of myelination was subsequently analyzed by light microscopy (Olympus BX61).

Statistical analysis

All data are given as mean ± SEM. Multiple comparisons were performed using analysis of variance (ANOVA) test followed by the Dunn’s test. Significance was established when the P values were less than 0.05.


The functional impact of de- and remyelination on cellular properties

In the auditory cortex, layer 4 neurons are the first cellular elements in signal processing where thalamic sensory information is integrated and directed to other cortical layers [30]. To study the intrinsic firing properties of these A1 neurons, intracellular recordings were performed in combined brain slices containing the preserved thalamocortical auditory pathway [25].

Neurons from cuprizone-treated mice showed a significantly hyperpolarized RMP (−56.1 ± 0.8 mV) compared to control animals (−52.5 ± 0.4 mV; P < 0.001; Fig. 1a, b, Table 1). During the early phases of remyelination (7 days), neurons were characterized by a significantly more positive RMP (−51 ± 0.1 mV) compared to cuprizone and control mice (P < 0.001; Fig. 1a, b, Table 1). In the 25 days remyelination group, the RMP returned to a hyperpolarization state (−54.7 ± 0.4 mV), which was significantly lower than cuprizone and 7 days remyelination group (P < 0.001; Fig. 1a, b, Table 1). All neurons recorded revealed spontaneous AP firing with frequencies around 8 Hz. The duration of AHP of APs recorded from neurons in control mice as well as the 25 days remyelination group was significantly longer, and their amplitude was significantly higher compared to cuprizone-treated and 7 days remyelination mice (P < 0.001; Fig. 1a, b, Table 1). There were no significant differences in the repetition rate of APs between different groups (Fig. 1a, b, Table 1). Demyelination did not change the amplitude and duration of APs compared to control (Fig. 1a, Table 1). However, during the early and late phases of remyelination, the amplitude of APs significantly increased while their duration decreased (P < 0.001; Fig. 1a, b, Table 1). Demyelination as well as remyelination at both points in time revealed significantly reduced differences between prevailing membrane potential shortly before and the threshold potential of APs (P < 0.001; Fig. 1a, Table 1).

Fig. 1
figure 1

The membrane potential fluctuations recorded from layer 4 of the neocortical A1 area in control, cuprizone, 7 days remyelination, and 25 days remyelination mice groups. a Representative traces of the spontaneous membrane potential fluctuations in each mice group and a diagram of the thalamocortical slice, indicating recording site for intracellular recordings. b The resting membrane potentials (RMP), repetition rate of action potentials (APs), the amplitude and duration of APs, and afterhyperpolarizations (AHP) of APs in different mouse groups revealed the effect of demyelination and remyelination on different characteristic features of neuronal activities. *P < 0.001

Table 1 Characteristics of membrane potential alteration in the primary auditory cortex in control, cuprizone, 7 days remyelination, and 25 days remyelination mouse groups

Hyperpolarization of A1 neurons to −70 mV reduced spontaneous AP firing (Fig. 2a). Under control condition, the AP threshold was significantly larger compared to cuprizone as well as the early and late remyelination groups (P < 0.001; Fig. 2a, Table 1). Neurons recorded from slices after 25 days of remyelination exhibited a larger and longer AHP of APs when hyperpolarized to −70 mV compared to cuprizone and 7 days remyelination groups (P < 0.001; Fig. 2a, Table 1). There was no significant difference in the amplitude of APs between all groups when neurons were hyperpolarized to −70 mV (Fig. 2a, Table 1). However, hyperpolarization of neurons to −70 mV significantly decreased the duration of APs in slices from mice after 7 days of remyelination compared to other groups (Fig. 2a, Table 1).

Fig. 2
figure 2

Intracellular injection of a constant positive or negative current was used to investigate how APs and AHP change at hyperpolarized (−70 mV) and depolarized (−40 mV) states of the membrane in neurons of layer 4 of the neocortical A1 area in control, cuprizone, 7 days remyelination, and 25 days remyelination mouse groups. Representative traces of the membrane potential deflections at −70 mV (a) and −40 mV (b) of neurons in different mouse groups are shown

When neurons were depolarized to −40 mV, spontaneous firing increased under all experimental conditions (Fig. 2b). Comparing the amplitude and duration of APs from neurons of slices prepared from control and cuprizone-treated animals revealed no significant difference (Fig. 2b, Table 1). However, the amplitude of APs in preparations obtained from 7 and 25 days remyelination mice was higher than APs of cuprizone-treated mice (P < 0.001; Fig. 2b, Table 1). Depolarization of neurons to −40 mV significantly increased the amplitude and duration of the AHP of APs, as well as the duration of APs, in slices after 25 days of remyelination compared to slices from cuprizone and 7 days remyelination mice (P < 0.001; Fig. 2b, Table 1).

Next, AP firing was induced by applying depolarizing current steps through the microelectrode (120 ms; 100 pA). Neurons from cuprizone-treated and 7 days remyelination animals exhibited longer interspike intervals compared to control mice, indicating slower spiking (P < 0.001; Fig. 3a, b). There were no significant differences in the frequency of APs and the amplitude of depolarization step after current injection among different groups.

Fig. 3
figure 3

Typical discharge patterns of A1 cortical neurons from control, cuprizone, 7 days remyelination, and 25 days remyelination mice induced by intracellular injection of square positive current pulses (120 ms; 100 pA). a Representative traces of the discharge patterns induced at resting membrane potentials of −52 mV in different mice groups and a diagram of the thalamocortical slice, indicating recording site for intracellular recordings. b Group of bars represents the mean ± S.E.M. of the interspike intervals (between the first and the second APs) between different mouse groups. Note that the neurons from cuprizone-treated animals exhibited longer interspike intervals compared to control and 7 days remyelination mice. *P < 0.001

The effect of de- and remyelination on EPSP and IPSP

To study the characteristics of synaptic transmission, EPSPs and IPSPs were evoked by the stimulation of the thalamocortical projections in rostral position with respect to the cortex during intracellular recordings of A1 neurons (with ~50 % failure rate). The synaptic delay of IPSPs and EPSPs evoked by thalamocortical stimulation was about 3–4 ms. There were no significant differences in the amplitude and duration of IPSPs between different animal groups (Fig. 4a, b). However, the amplitude of EPSPs was significantly lower in cuprizone mice compared to other groups (P < 0.001; Fig. 4a, b). In addition, the duration of EPSPs was significantly longer in slices obtained from 25 days remyelination mice compared to the other groups (P < 0.001; Fig. 4a, b). The duration of EPSPs in control mice were also shorter than in the other groups (P < 0.001; Fig. 4a, b).

Fig. 4
figure 4

Excitatory and inhibitory postsynaptic potentials (EPSP and IPSP) recorded by neurons of layer 4 of A1 neocortex after stimulation of thalamocortical pathways (diagram) in control, cuprizone, 7 days remyelination, and 20 days remyelination mice. a Representative traces of EPSP and IPSP in different mice group. b Group of bars represents the mean ± S.E.M. of the amplitude and duration of EPSPs and IPSPs in different mouse groups. *P < 0.001

The effect of de-and remyelination on LTP

To assess possible changes in long-lasting synaptic plasticity, a conditioning tetanic stimulation was delivered to the internal capsule of thalamocortical slices after 30 min of stable recording and followed by pulses with stimulation parameters identical to control levels. Application of tetanic stimulation produced a stable and lasting enhancement of the amplitude of fEPSPs in all tested slices of control mice (n = 13, 163.6 ± 5.7 % control; Fig. 5a, b). Demyelination following cuprizone treatment significantly reduced LTP induction in A1 from all tested slices (n = 14, 137.2 ± 3.7 % baselines, P < 0.05, Fig. 5a, b). During the early remyelination phase, LTP recovered to a level of 161 ± 3.9 % of baseline which was significantly increased compared to the potentiation under control conditions (n = 10, P < 0.05, Fig. 5a, b). However, during the late phase of remyelination, the degree of LTP decreased to 135.6 ± 3.6 % of baseline (n = 15, P = 0.001, Fig. 5a, b).

Fig. 5
figure 5

Long-term potentiation (LTP) of the evoked field excitatory postsynaptic potentials (fEPSPs) in the neocortical A1 area induced by a conditioning tetanic stimulation delivered to the thalamocortical pathway of combined neocortical slices (diagram). a Tetanic stimulation (four trains of 100-ms long train of 100-Hz electrical pulses, pulse duration 0.1 ms, interpulse interval 10 ms, train interval of 100 ms) produces a potentiation in the amplitude of the evoked field potentials, calculated as a percentage of baseline mean response amplitude. Solid circles, open circles, solid square, and solid triangles show the evoked fEPSP in control, cuprizone, 7 days remyelination, and 20 days remyelination mouse groups, respectively. Arrow points the time of tetanic stimulation. The time points given refer to LTP induction. Demyelination following cuprizone treatment significantly reduced LTP induction. During the early remyelination phase (7 days), LTP of fEPSP returned to control levels. However, the ratio of LTP decreased during the late (25 days) phase of remyelination. b Representative examples of the evoked field potentials before and after tetanic stimulation in different experimental groups. Values represent mean ± SEM

Histological evaluation of de- and remyelination in the cuprizone model

Treatment with cuprizone is a well-established model of general demyelination usually occurring after 5–6 weeks of administration in mice. In line with previous studies [22, 27], myelin content was decreased of 83 % of the control value in the primary auditory cortex and 34 % in the medial geniculate nucleus, which are parts of a reciprocally connected network (Fig. 6). Termination of cuprizone treatment by administration of normal food allowed remyelination, which reach the maximal recovery after about 4 weeks [23, 24]. Indeed, myelin content after 25 days increased in the primary auditory cortex by 66 % compared to the cuprizone group. In the medial geniculate nucleus, myelin content returned to the control value in the same period (Fig. 6).

Fig. 6
figure 6

Representative micrographs of the primary auditory cortex and the medial geniculate nucleus in the control group, cuprizone group, and 7 days as well as 25 days remyelination groups. Treatment with the copper chelator cuprizone after 5–6 weeks induced demyelination in both the primary auditory cortex and the medial geniculate nucleus (cuprizone group). Termination of cuprizone treatment and administration of normal food allowed remyelination (7 days and 25 days remeylination groups)


Our results revealed the impact of myelin integrity on firing properties and synaptic transmission of neurons in the auditory thalamocortical system. Myelin loss and restoration affected cellular activities in thalamorecipient layer 4 as well as cortical synaptic transmission in the third layer of the auditory cortex. In addition, the early and late phases of remyelination differentially changed neuronal excitability and synaptic plasticity of cuprizone-treated mice.

Myelination of the thalamic projections innervating the auditory cortex begins around 1 year of age and progresses until the fourth year [31]. The main thalamocortical input from the ventral part of the medial geniculate body of the thalamus is directed in a tonotopic manner to layer 4 of the A1 [32]. The information from cells in layer 4 of the auditory cortex project to the pyramidal neurons of layer 3, and from there, the inputs are distributed to the other cortical layers of both the ipsilateral and the contralateral auditory cortex through the corpus callosum. The corpus callosum, the largest fiber tract in the brain, is affected in most cases of MS patients as well as in cuprizone-treated mice [33, 34]. The isthmus of the corpus callosum contains fibers from the motor, the somatosensory, and the primary auditory cortices [34]. Our results revealed that demyelination altered thalamocortical inputs in primary auditory cortex, which might produce difficulty with sensory perception in MS [35]. Using diffusion tensor imaging fiber tracking, a tenfold higher density of lesions in thalamocortical projections compared to other brain white matter regions was observed [36].

Our data revealed a decreased excitability of layer 4 neurons from A1 in cuprizone-treated mice, characterized by more negative RMPs, longer evoked spiking intervals, and smaller EPSPs. Axonal demyelination increases stability of the membrane potential and leads to impaired neuronal function in demyelinating diseases by increasing the input capacitance and changing the surface exposure of ionic channels, especially K+ channels [37]. In the present study, layer 4 neurons revealed a significant hyperpolarization of the RMP after cuprizone treatment. Intracellular recording from A1 neurons has shown that depolarization and hyperpolarization of the membrane potential underlie excitatory-inhibitory response properties to thalamic inputs [38]. Alterations of depolarizing shifts have been also reported in the membrane potential of peripheral nerves when recordings were performed near the site of demyelination [5]. In contrast to layer 4 neurons in our study, demyelination of the axon of layer 5 neurons in the auditory cortex causes spontaneous intrinsic and network excitability of pyramidal neurons of cuprizone-treated mice [7]. In addition to the well-known effect of layer 4 neurons to drive feed-forward and recurrent inhibition in other cortical layers [39, 40], it has been shown that enhanced layer 4 activity directly suppressed layer 5 neurons by activating deep, fast-spiking inhibitory neurons in awake, behaving mice [41]. A pronounced reduction in layer 4 activity by hyperpolarization of neurons enhanced layer 5 firing and broadened the representation of horizontal space across the population of layer 5 regular spiking neurons [41]. Hyperpolarization and decreased excitability of layer 4 neurons observed in cuprizone-treated mice in our study caused disinhibition and thereby increased excitability in other cortical layers. Disturbed spatiotemporal connections between different areas of cortical networks have been suggested to underlie cognitive impairment, commonly observed in MS patients [41, 42]. Damage to heterogeneous profiles of myelination of different neocortical layers may disorganize different arrays of inter-layer communication and prevent the emergence of complex cellular behaviors [43].

In general, it has been shown that the spatiotemporal patterns of de- and remyelination vary across the brain after 6 weeks of cuprizone administration and subsequent remyelination. This suggests varying susceptibility to injury and/or ability to repair in the brain in the cuprizone mouse model [44]. Therefore, partially diversified results may be expected. Following cessation of a 6-week cuprizone diet, demyelinated lesions demonstrate about 50 % recovery after 1 week and an almost complete remyelination was observed within 4 weeks [45]. Our data indicate a partial recovery of neuronal excitability and synaptic plasticity in the early and late phases of remyelination. In keeping with our results, it has been shown that while immunohistochemical staining points to extensive remyelination, neurotransmission along previously demyelinated neuronal tissue has not been completely recovered to normal [46]. Following 6 weeks of cuprizone ingestion, the recovery of action potentials was incomplete in an ex vivo slice preparations model even after feeding with normal chow for another 6 weeks [47]. In a similar way, cuprizone feeding increased the response latency between the left and right sensorimotor cortices and only partial recovery of axonal conduction was observed after remyelination [48]. Early periods of remyelination, prior to new myelin formation, are associated with a redistribution and reaggregation of sodium channels close to the lesion site, a process that may render neurons more susceptible to injury [49]. It has been shown that production of de novo synapses with recruited oligodendrocyte progenitor cells by demyelinated bioelectrically active axons and release of glutamate are crucial for remyelination and recovery of lost function [50]. Different subtypes of sodium channel that are expressed during remyelination, as well as the effect of inflammatory mediators on its function, may be responsible for alterations of neuronal properties in the early and late phases of myelin restoration [51].

In our study, EPSPs evoked by stimulation of the thalamocortical projections in the control group were mainly monosynaptic in its early part and polysynaptic in its late part. The late components appeared with a smooth time course since the velocity of transmission in the pathways involved was not very different. Cuprizone-induced demyelination flattened the EPSPs as expected for demyelination. The late EPSPs became multiphasic during the remyelination process after both 7 and 25 days after withdrawal of cuprizone. It can be assumed that this is due to the alteration of the synaptic network which followed alterations in axonal conduction velocities on the basis of partial and/or patchy remyelination, thus leading to prolonged multiphasic EPSPs [52].

Our data indicated that demyelination reduced the amplitude of EPSPs and decreased synaptic plasticity at cortical synapses in the auditory cortex. Remyelination after 7 days restored the synaptic strength in these synapses. However, further remyelination was associated with impairment of LTP. In vivo intracellular recordings of the primary auditory cortex have shown that modulation of synaptic plasticity in this region is a prominent feature of synaptic responses to auditory stimuli [53]. These observations are in keeping with our results that LTP in the hippocampal CA1 area was decreased and LTP-related spatial memory was impaired in animal models of MS [54, 55]. Conversely, some other studies found no differences in hippocampal LTP between demyelinated and normal neuronal network [56]. Clinical studies indicate that the degree of neuroinflammation is associated with changes of LTP in MS patients [10]. It has been suggested that synaptic plasticity may be enhanced or impaired during experimental and clinical demyelination-remeylination, depending on the degree of neuroinflammation and the time point at which it is investigated [57].


Our data indicate altered neuronal and synaptic activities between the thalamus and auditory cortex in the cuprizone model of demyelination/remyelination. Demyelination and remyelination differentially affect the characteristic features of neuronal activities and synaptic plasticity in the thalamocortical auditory system. Further studies are needed to clarify whether these alterations reflect the degree of neuroinflammation as well as the extent of clinical manifestations of MS.


AHP, afterhyperpolarizations; APs, action potentials; EPSPs, excitatory postsynaptic potentials; fEPSPs, field excitatory postsynaptic potentials; IPSPs, inhibitory postsynaptic potentials; LTP, long-term potentiation; MS, multiple sclerosis; PFA, paraformaldehyde; PLP, myelin proteolipid protein; RMP, resting membrane potential; THP, the threshold potential of action potentials


  1. Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007;17:210–8.

    Article  PubMed  Google Scholar 

  2. Duncan ID, Brower A, Kondo Y, Curlee Jr JF, Schultz RD. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci U S A. 2009;106:6832–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fields RD. A new mechanism of nervous system plasticity: activity-dependent myelination. Nat Rev Neurosci. 2015;16:756–67.

    Article  CAS  PubMed  Google Scholar 

  4. Rasminsky M, Kearney RE, Aguayo AJ, Bray GM. Conduction of nervous impulses in spinal roots and peripheral nerves of dystrophic mice. Brain Res. 1978;143:71–85.

    Article  CAS  PubMed  Google Scholar 

  5. Felts PA, Kapoor R, Smith KJ. A mechanism for ectopic firing in central demyelinated axons. Brain. 1995;118:1225–31.

    Article  PubMed  Google Scholar 

  6. Kapoor R, Li YG, Smith KJ. Slow sodium-dependent potential oscillations contribute to ectopic firing in mammalian demyelinated axons. Brain. 1997;120:647–52.

    Article  PubMed  Google Scholar 

  7. Hamada MS, Kole MH. Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability. J Neurosci. 2015;35:7272–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mori F, Kusayanagi H, Buttari F, Centini B, Monteleone F, Nicoletti CG, Bernardi G, Di Cantogno EV, Marciani MG, Centonze D. Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deficits in multiple sclerosis. Funct Neurol. 2012;27:163–8.

    PubMed  Google Scholar 

  9. Kim do Y, Hao J, Liu R, Turner G, Shi FD, Rho JM. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS ONE. 2012;7:e35476.

    Article  PubMed  Google Scholar 

  10. Mori F, Kusayanagi H, Nicoletti CG, Weiss S, Marciani MG, Centonze D. Cortical plasticity predicts recovery from relapse in multiple sclerosis. Mult Scler. 2014;20:451–7.

    Article  PubMed  Google Scholar 

  11. Liu X, Basavaraj S, Krishnan R, Yan J. Contributions of the thalamocortical system towards sound-specific auditory plasticity. Neurosci Biobehav Rev. 2011;35:2155–61.

    Article  PubMed  Google Scholar 

  12. O’Muircheartaigh J, Vollmar C, Barker GJ, Kumari V, Symms MR, Thompson P, Duncan JS, Koepp MJ, Richardson MP. Abnormal thalamocortical structural and functional connectivity in juvenile myoclonic epilepsy. Brain. 2012;135:3635–44.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Nair A, Treiber JM, Shukla DK, Shih P, Müller RA. Impaired thalamocortical connectivity in autism spectrum disorder: a study of functional and anatomical connectivity. Brain. 2013;136:1942–55.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Moyer CE, Delevich KM, Fish KN, Asafu-Adjei JK, Sampson AR, Dorph-Petersen KA, Lewis DA, Sweet RA. Intracortical excitatory and thalamocortical boutons are intact in primary auditory cortex in schizophrenia. Schizophr Res. 2013;149:127–34.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Minagar A, Barnett MH, Benedict RH, Pelletier D, Pirko I, Sahraian MA, Frohman E, Zivadinov R. The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology. 2013;80:210–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Mustillo P. Auditory deficits in multiple sclerosis: a review. Audiology. 1984;23:145–64.

    Article  CAS  PubMed  Google Scholar 

  17. Dell’Acqua ML, Landi D, Zito G, Zappasodi F, Lupoi D, Rossini PM, Filippi MM, Tecchio F. Thalamocortical sensorimotor circuit in multiple sclerosis: an integrated structural and electrophysiological assessment. Hum Brain Mapp. 2010;31:1588–600.

    Article  PubMed  Google Scholar 

  18. Bergamaschi R, Romani A, Zappoli F, Versino M, Cosi V. MRI and brainstem auditory evoked potential evidence of eighth cranial nerve involvement in multiple sclerosis. Neurology. 1997;48:270–2.

    Article  CAS  PubMed  Google Scholar 

  19. Kallmann BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis. Mult Scler. 2006;12:58–65.

    Article  CAS  PubMed  Google Scholar 

  20. Matas CG, Matas SL, Oliveira CR, Gonçalves IC. Auditory evoked potentials and multiple sclerosis. Arq Neuropsiquiatr. 2010;68:528–34.

    Article  PubMed  Google Scholar 

  21. Vakilzadeh G, Khodagholi F, Ghadiri T, Darvishi M, Ghaemi A, Noorbakhsh F, Gorji A, Sharifzadeh M. Protective effect of a cAMP analogue on behavioral deficits and neuropathological changes in cuprizone model of demyelination. Mol Neurobiol. 2015;52:130–41.

    Article  CAS  PubMed  Google Scholar 

  22. Vakilzadeh G, Khodagholi F, Ghadiri T, Ghaemi A, Noorbakhsh F, Sharifzadeh M, Gorji A. The effect of melatonin on behavioral, molecular, and histopathological changes in cuprizone model of demyelination. Mol Neurobiol. 2015 Aug 27. [Epub ahead of print].

  23. Gudi V, Gingele S, Skripuletz T, Stangel M. Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front Cell Neurosci. 2014;8:73.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Skripuletz T, Gudi V, Hackstette D, Stangel M. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. Histol Histopathol. 2011;26:1585–97.

    CAS  PubMed  Google Scholar 

  25. Broicher T, Bidmon HJ, Kamuf B, Coulon P, Gorji A, Pape HC, Speckmann EJ, Budde T. Thalamic afferent activation of supragranular layers in auditory cortex in vitro: a voltage sensitive dye study. Neuroscience. 2010;165:371–85.

    Article  CAS  PubMed  Google Scholar 

  26. Ghadiri MK, Kozian M, Ghaffarian N, Stummer W, Kazemi H, Speckmann EJ, Gorji A. Sequential changes in neuronal activity in single neocortical neurons after spreading depression. Cephalalgia. 2012;32:116–24.

    Article  PubMed  Google Scholar 

  27. Mesgari M, Ghaffarian N, Khaleghi Ghadiri M, Sadeghian H, Speckmann EJ, Stummer W, Gorji A. Altered inhibition in the hippocampal neural networks after spreading depression. Neuroscience. 2015;304:190–7.

    Article  CAS  PubMed  Google Scholar 

  28. Anderson WW, Collingridge GL. Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J Neurosci Methods. 2007;162:346–56.

    Article  PubMed  Google Scholar 

  29. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol. 2008;172:1053–61.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Smith PH, Populin LC. Fundamental differences between the thalamocortical recipient layers of the cat auditory and visual cortices. J Comp Neurol. 2001;436:508–19.

    Article  CAS  PubMed  Google Scholar 

  31. Moore DR. Auditory development and the role of experience. Br Med Bull. 2002;63:171–81.

    Article  CAS  PubMed  Google Scholar 

  32. Kratz MB, Manis PB. Spatial organization of excitatory synaptic inputs to layer 4 neurons in mouse primary auditory cortex. Front Neural Circuits. 2015;9:17.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain. 2000;123:1845–9.

    Article  PubMed  Google Scholar 

  34. Raybaud C. The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation. Neuroradiology. 2010;52:447–77.

    Article  PubMed  Google Scholar 

  35. Steelman AJ, Thompson JP, Li J. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication. Neurosci Res. 2012;72:32–42.

    Article  CAS  PubMed  Google Scholar 

  36. Henry RG, Shieh M, Amirbekian B, Chung S, Okuda DT, Pelletier D. Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci. 2009;282:61–6.

    Article  PubMed  Google Scholar 

  37. Baker M, Bostock H. Ectopic activity in demyelinated spinal root axons of the rat. J Physiol. 1992;451:539–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Ojima H, Murakami K. Intracellular characterization of suppressive responses in supragranular pyramidal neurons of cat primary auditory cortex in vivo. Cereb Cortex. 2002;12:1079–91.

    Article  PubMed  Google Scholar 

  39. Tarczy-Hornoch K, Martin KAC, Jack JJB, Stratford KJ. Synaptic interactions between smooth and spiny neurones in layer 4 of cat visual cortex in vitro. J Physiol Lond. 1998;508:351–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Helmstaedter M, Staiger JF, Sakmann B, Feldmeyer D. Efficient recruitment of layer 2/3 interneurons by layer 4 input in single columns of rat somatosensory cortex. J Neurosci. 2008;28:8273–84.

    Article  CAS  PubMed  Google Scholar 

  41. Pluta S, Naka A, Veit J, Telian G, Yao L, Hakim R, Taylor D, Adesnik H. A direct translaminar inhibitory circuit tunes cortical output. Nat Neurosci. 2015;18:1631–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bendfeldt K, Kappos L, Radue EW, Borgwardt S. Longitudinal spatiotemporal distribution of gray and white matter pathology in multiple sclerosis. AJNR Am J Neuroradiol. 2010;31:E45.

    Article  CAS  PubMed  Google Scholar 

  43. Tomassy GS, Berger DR, Chen HH, Kasthuri N, Hayworth KJ, Vercelli A, Seung HS, Lichtman JW, Arlotta P. Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex. Science. 2014;344:319–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Tagge I, O’Connor A, Chaudhary P, Pollaro J, Berlow Y, Chalupsky M, Bourdette D, Woltjer R, Johnson M, Rooney W. Spatio-temporal patterns of demyelination and remyelination in the cuprizone mouse model. PLoS ONE. 2016;11:e0152480.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001;11:107–16.

    Article  CAS  PubMed  Google Scholar 

  46. Hibbits N, Pannu R, Wu TJ, Armstrong RC. Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination. ASN Neuro. 2009;1:153-164.

  47. Crawford DK, Mangiardi M, Xia X, López-Valdés HE, Tiwari-Woodruff SK. Functional recovery of callosal axons following demyelination: a critical window. Neuroscience. 2009;164:1407–21.

    Article  CAS  PubMed  Google Scholar 

  48. Bando Y, Takakusaki K, Ito S, Terayama R, Kashiwayanagi M, Yoshida S. Differential changes in axonal conduction following CNS demyelination in two mouse models. Eur J Neurosci. 2008;28:1731–42.

    Article  PubMed  Google Scholar 

  49. Smith PM, Jeffery ND. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol. 2006;16:99–109.

    Article  PubMed  Google Scholar 

  50. Gautier HO, Evans KA, Volbracht K, James R, Sitnikov S, Lundgaard I, James F, Lao-Peregrin C, Reynolds R, Franklin RJ, Káradóttir RT. Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors. Nat Commun. 2015;6:8518.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Smith KJ. Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathol. 2007;17:230–42.

    Article  CAS  PubMed  Google Scholar 

  52. Rose HJ, Metherate R. Auditory thalamocortical transmission is reliable and temporally precise. J Neurophysiol. 2005;94:2019–30.

    Article  PubMed  Google Scholar 

  53. Wehr M, Zador AM. Synaptic mechanisms of forward suppression in rat auditory cortex. Neuron. 2005;47:437–45.

    Article  CAS  PubMed  Google Scholar 

  54. Di Filippo M, Chiasserini D, Gardoni F, Viviani B, Tozzi A, Giampà C, Costa C, Tantucci M, Zianni E, Boraso M, Siliquini S, de Iure A, Ghiglieri V, Colcelli E, Baker D, Sarchielli P, Fusco FR, Di Luca M, Calabresi P.. Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis. 2013;52:229–36.

    Article  PubMed  Google Scholar 

  55. Novkovic T, Shchyglo O, Gold R, Manahan-Vaughan D. Hippocampal function is compromised in an animal model of multiple sclerosis. Neuroscience. 2015;309:100–12.

    Article  CAS  PubMed  Google Scholar 

  56. Prochnow N, Gold R, Haghikia A. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2013;264:48–53.

    Article  CAS  PubMed  Google Scholar 

  57. Weiss S, Mori F, Rossi S, Centonze D. Disability in multiple sclerosis: when synaptic long-term potentiation fails. Neurosci Biobehav Rev. 2014;43:88–99.

    Article  PubMed  Google Scholar 

Download references


Not applicable.


This study was supported by the CRC SFB-128 (B6, to SGM and TB) as well as by grants from Novartis Pharma and Biogen Idec.

Availability of data and materials

The data will not be shared due to the huge amounts of raw electrophysiology data.

Authors’ contributions

NG and MM carried out the electrophysiology studies and analyzed the data; MC participated in the study coordination and helped to draft the manuscript; KG carried out the histological studies; TB participated in the design of the study and helped to draft the manuscript; EJS conceived the study and participated in the electrophysiology study; SGM designed the study, supervised the whole study, and helped to draft the manuscript; and AG supervised the electrophysiology studies and drafted the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval

All experiments were conducted according to the guiding principles for the care and use of animals in the University of Münster, Germany (LANUV approval AZ 87-51.04.2010.A331).

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Sven G. Meuth or Ali Gorji.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghaffarian, N., Mesgari, M., Cerina, M. et al. Thalamocortical-auditory network alterations following cuprizone‐induced demyelination. J Neuroinflammation 13, 160 (2016).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: